ARCHIVES

EGFR Inhibitor Shrinks Tumors In Phase I Study of Patients With Treatment-Resistant Mutation

This article is from The Cancer Letter archive.

Vol. 37 No. 5 | May 30, 2014

Download PDF Visit The Full Archive

Related Articles

President Obama Signs FDA User Fee Act Into Law

July 13, 2012

Public Health Service: Scientific Papers Become “Deliverables” In Own RFP

October 3, 1997

Elias Zerhouni Nominated for NIH Director; Richard Carmona For Surgeon General

April 5, 2002

Two Cooperative Groups Renamed ECOG-ACRIN

September 23, 2011

Has The Pendulum Swing too Far Toward Grants? NCI, NCAB Ponder Best Way to Stimulate Work In New areas

December 5, 1980

New Cancer Control Approaches May Include CCRU RFA, Center Cooperative Groups, Regional “Rounds”

March 18, 1983